IL-6 could represent an interesting prognostic biomarker, although not specific, as increased CSF IL-6 concentrations have been linked to worse disease severity also in neurological inflammatory conditions other than MS (Matsushita et al., 2013; Wang et al., 2015). The gene discussed is IL6; the disease is myeloid sarcoma.